Moore, C.* ; Blumhagen, R.Z.* ; Yang, I.V.* ; Walts, A.* ; Powers, J.* ; Walker, T.* ; Bishop, M.* ; Russell, P.* ; Vestal, B.* ; Cardwell, J.* ; Markin, C.R.* ; Mathai, S.K.* ; Schwarz, M.I.* ; Steele, M.P.* ; Lee, J.* ; Brown, K.K.* ; Loyd, J.E.* ; Crapo, J.D.* ; Silverman, E.K.* ; Cho, M.H.* ; James, J.A.* ; Guthridge, J.M.* ; Cogan, J.D.* ; Kropski, J.A.* ; Swigris, J.J.* ; Bair, C.* ; Soon Kim, D.* ; Ji, W.* ; Kim, H.* ; Song, W.J.* ; Maier, L.A.* ; Pacheco, K.A.* ; Hirani, N.* ; Poon, A.S.* ; Li, F.* ; Jenkins, R.G.* ; Braybrooke, R.* ; Saini, G.* ; Maher, T.M.* ; Molyneaux, P.L.* ; Saunders, P.* ; Zhang, Y.* ; Gibson, K.F.* ; Kass, D.J.* ; Rojas, M.* ; Sembrat, J.* ; Wolters, P.J.* ; Collard, H.R.* ; Sundy, J.S.* ; O'Riordan, T.* ; Strek, M.E.* ; Noth, I.* ; Ma, S.F.* ; Porteous, M.K.* ; Kreider, M.E.* ; Patel, N.B.* ; Inoue, Y.* ; Hirose, M.* ; Arai, T.* ; Akagawa, S.* ; Eickelberg, O. ; Fernandez, I.E. ; Behr, J.* ; Mogulkoc, N.* ; Corte, T.J.* ; Glaspole, I.* ; Tomassetti, S.* ; Ravaglia, C.* ; Poletti, V.* ; Crestani, B.* ; Borie, R.* ; Kannengiesser, C.* ; Parfrey, H.* ; Fiddler, C.* ; Rassl, D.* ; Molina-Molina, M.* ; Machahua, C.* ; Montes Worboys, A.* ; Gudmundsson, G.* ; Isaksson, H.J.* ; Lederer, D.J.* ; Podolanczuk, A.J.* ; Montesi, S.B.* ; Bendstrup, E.* ; Danchel, V.* ; Selman, M.* ; Pardo, A.* ; Henry, M.T.* ; Keane, M.P.* ; Doran, P.* ; Vašáková, M.* ; Sterclova, M.* ; Ryerson, C.J.* ; Wilcox, P.G.* ; Okamoto, T.* ; Furusawa, H.* ; Miyazaki, Y.* ; Laurent, G.* ; Baltic, S.* ; Prele, C.* ; Moodley, Y.* ; Shea, B.S.* ; Ohta, K.* ; Suzukawa, M.* ; Narumoto, O.* ; Nathan, S.D.* ; Venuto, D.C.* ; Woldehanna, M.L.* ; Kokturk, N.* ; de Andrade, J.A.* ; Luckhardt, T.* ; Kulkarni, T.* ; Bonella, F.* ; Donnelly, S.C.* ; McElroy, A.* ; Armstrong, M.E.* ; Aranda, A.* ; Carbone, R.G.* ; Puppo, F.* ; Beckman, K.B.* ; Nickerson, D.A.* ; Fingerlin, T.E.* ; Schwartz, D.A.*
Resequencing study confirms host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis.
Am. J. Respir. Crit. Care Med. 200, 199-208 (2019)
Rationale: Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung.Objectives: To develop an integrated understanding of the rare and common variants located in multiple loci that have been reported to contribute to the risk of disease.Methods: We performed deep targeted resequencing (3.69 Mb of DNA) in cases (n = 3,624) and control subjects (n = 4,442) across genes and regions previously associated with disease. We tested for associations between disease and 1) individual common variants via logistic regression and 2) groups of rare variants via sequence kernel association tests.Measurements and Main Results: Statistically significant common variant association signals occurred in all 10 of the regions chosen based on genome-wide association studies. The strongest risk variant is the MUC5B promoter variant rs35705950, with an odds ratio of 5.45 (95% confidence interval, 4.91-6.06) for one copy of the risk allele and 18.68 (95% confidence interval, 13.34-26.17) for two copies of the risk allele (P = 9.60 x 10(-295)). In addition to identifying for the first time that rare variation in FAM13A is associated with disease, we confirmed the role of rare variation in the TERT and RTEL1 gene regions in the risk of IPF, and found that the FAM13A and TERT regions have independent common and rare variant signals.Conclusions: A limited number of common and rare variants contribute to the risk of idiopathic pulmonary fibrosis in each of the resequencing regions, and these genetic variants focus on biological mechanisms of host defense and cell senescence.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Targeted Resequencing ; Idiopathic Pulmonary Fibrosis ; Genetic Variants ; Rare Variants ; Disease Risk Alleles; Muc5b Promoter Polymorphism; Genome; Susceptibility; Mutations; Association; Expression; Disease; Loci
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2019
Prepublished im Jahr
HGF-Berichtsjahr
2019
ISSN (print) / ISBN
1073-449X
e-ISSN
1535-4970
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 200,
Heft: 2,
Seiten: 199-208
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
American Thoracic Society
Verlagsort
25 Broadway, 18 Fl, New York, Ny 10004 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30202 - Environmental Health
Forschungsfeld(er)
Lung Research
PSP-Element(e)
G-501600-001
Förderungen
Copyright
Erfassungsdatum
2019-05-13